ORIGINAL PAPER
Awareness, standpoint, and inclinations towards human papilloma virus vaccination among University of Jordan Medical Students: a cross-sectional study
1
Department of Obstetrics and Gynecology, The University of Jordan, Amman, Jordan
These authors had equal contribution to this work
Submission date: 2024-10-12
Final revision date: 2024-12-13
Acceptance date: 2025-04-28
Publication date: 2025-12-22
Corresponding author
Kamil M. Fram
Kamil M. Fram Department of Obstetrics and Gynecology The University of Jordan Amman, Jordan
Kamil M. Fram Department of Obstetrics and Gynecology The University of Jordan Amman, Jordan
Medical Studies 2025;41(4):424-429
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Human papillomavirus (HPV) is a significant risk factor for the development of cervical malignancy. The overall death toll due to cervical carcinoma is remarkable. The HPV vaccine is a well-known primary preventive measure for HPV infections, but it has not yet been introduced in Jordan.
Aim of the research:
The study aims to examine the point of view of medical students at the University of Jordan who want to be vaccinated against HPV infection.
Material and methods:
This cross-sectional survey was carried out between August 2023 and April 2024, during which time 327 participants who were senior students at the School of Medicine of the University of Jordan were interviewed using a validated and structured questionnaire.
Results:
Over 96% of the students were aware of cervical cancer and HPV, but only 89% knew about the HPV vaccine and its safety before participating in the study. The students showed highly favourable attitudes toward the HPV vaccine, with an acceptance rate of 84.1%. Nevertheless, some students were willing to be vaccinated but were unaware of the vaccine. However, the high cost and insufficient dissemination of HPV-related information were significant obstacles to vaccine uptake in Jordan. Most participants were female (202), while 125 were male.
Conclusions:
Medical students’ knowledge about the HPV vaccine was high, and they had good attitudes, which are vital in recommending the vaccine and subsequent uptake, considering the health advocate’s weakness through the media.
Human papillomavirus (HPV) is a significant risk factor for the development of cervical malignancy. The overall death toll due to cervical carcinoma is remarkable. The HPV vaccine is a well-known primary preventive measure for HPV infections, but it has not yet been introduced in Jordan.
Aim of the research:
The study aims to examine the point of view of medical students at the University of Jordan who want to be vaccinated against HPV infection.
Material and methods:
This cross-sectional survey was carried out between August 2023 and April 2024, during which time 327 participants who were senior students at the School of Medicine of the University of Jordan were interviewed using a validated and structured questionnaire.
Results:
Over 96% of the students were aware of cervical cancer and HPV, but only 89% knew about the HPV vaccine and its safety before participating in the study. The students showed highly favourable attitudes toward the HPV vaccine, with an acceptance rate of 84.1%. Nevertheless, some students were willing to be vaccinated but were unaware of the vaccine. However, the high cost and insufficient dissemination of HPV-related information were significant obstacles to vaccine uptake in Jordan. Most participants were female (202), while 125 were male.
Conclusions:
Medical students’ knowledge about the HPV vaccine was high, and they had good attitudes, which are vital in recommending the vaccine and subsequent uptake, considering the health advocate’s weakness through the media.
REFERENCES (38)
1.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209-249.
2.
Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, Markowitz LE, Broutet N, Taylor M. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health. 2023; 11(9): e1345-e1362.
3.
Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014; 41(11): 660-664.
4.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Gali- chet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4): 321-322.
6.
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020; 8(2): e180-e190.
7.
McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2021; 20: 95-108.
8.
Giuliano AR, Nyitray AG, Kreimer AR, Pierce Camp- bell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015; 136(12): 2752-2760.
9.
Hoes J, King AJ, van’t Klooster TM, Berkhof J, Bogaards JA, de Melker HE. Vaccine effectiveness following routine immunization with bivalent human papillomavirus (HPV) vaccine: protection against incident genital HPV infections from a reduced-dosing schedule. J Infect Dis. 2022; 226(4): 634-643.
10.
Kusters JMA, van der Loeff MFS, van Benthem BHB, King AJ; PASSYON study group; de Melker HE, Heij- man T, Heijne JCM. Effectiveness of bivalent HPV vaccination against genital HPV DNA-positivity of a catch-up campaign at age 13–16 years compared to routine vaccination at age 12 years: a biennial repeated cross-sectional study. BMC Med 2024; 22: 469.
11.
Mlynarczyk-Bonikowska B, Rudnicka L. HPV infections – classification, pathogenesis, and potential new therapies. Int J Mol Sci 2024; 25: 7616.
12.
Haręża DA, Wilczyński JR, Paradowska E. Human papillomaviruses as infectious agents in gynecological cancers. oncogenic properties of viral proteins. Int J Mol Sci. 2022; 23(3): 1818.
13.
Kamolratanakul S, Pitisuttithum P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines (Basel). 2021; 9(12): 1413.
14.
Basukala O, Banks L. The not-so-good, the bad and the ugly: HPV E5, E6 and E7 oncoproteins in the orchestration of carcinogenesis. Viruses 2021; 13: 1892.
15.
Pathak P, Pajai S, Kesharwani H. A review on the use of the HPV vaccine to prevent cervical cancer. Cureus. 2022; 14(9): e28710.
16.
Sehnal B, Driák D, Džubáková Nipčová M, Sláma J. Current data on the efficacy of prophylactic HPV vaccination in the primary prevention of cervical lesions. Ceska Gynekol. 2022; 87(2): 124-130.
17.
Sehnal B, Pichlík T, Halaška MJ, Větrovská M, Babková A, Drozenová J, Robová H, Rob L. The efficacy of human papillomavirus vaccination in preventing recurrence of severe cervical lesions. Ceska Gynekol. 2023; 88(4): 294-300.
18.
Abdelaliem SMF, Kuaia AM, Hadadi AA, Alhujayri AK, Al Anazi AA, Hajar AA, AlShareda RS, Amri SM. Knowledge and attitudes toward human papillomavirus and vaccination: a survey among nursing students in Saudi Arabia. Healthcare (Basel). 2023; 11(12): 1766.
19.
Grandahl M, Oscarsson M, Stenhammar C, Nevéus T, Westerling R, Tydén T. Not the right time: why parents refuse to let their daughters have the human papillomavirus vaccination. Acta Paediatr. 2014; 103(4): 436-441.
20.
Gottvall M, Stenhammar C, Grandahl M. Parents’ views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study. BMJ Open. 2017; 7(2): e014255.
21.
Waller J, Forster A, Ryan M, Richards R, Bedford H, Marlow L. Decision-making about HPV vaccination in parents of boys and girls: a population-based survey in England and Wales. Vaccine. 2020; 38(5): 1040-1047.
22.
Park Y, Ki M, Lee H, Lee JK, Oh JK. Parental factors affecting decision to vaccinate their daughters against human papillomavirus. Cancer Prev Res (Phila). 2023; 16(3): 133-138.
23.
Si M, Jiang Y, Su X, Wang W, Zhang X, Gu X, Ma L, Li J, Zhang S, Ren Z, Liu Y, Qiao Y. Willingness to accept human papillomavirus vaccination and its influencing factors using information-motivation-behavior skills model. Cancer Control. 2021; 28: 10732748211032899.
24.
Wang H, Wang X, Chen P. Factors influencing Chinese female college students’ willingness to receive human papillomavirus vaccine: a cross-sectional study based on information-motivation-behavioral skills model. Hum Vaccin Immunother. 2022; 18(7): 2140550.
25.
Chen X, Xu T, Wu J, Sun C, Han X, Wang D, Zhang Z, Qiao C, Tao X. Exploring factors influencing awareness and knowledge of human papillomavirus in Chinese college students: a cross-sectional study. Hum Vaccin Immunother. 2024; 20(1): 2388347.
26.
Salwa M, Abdullah Al-Munim T. Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh. BMC Med Ethics. 2018; 19 (Suppl 1): 39.
27.
Haddad SF, Kerbage A, Eid R, Kourie HR. Awareness about the human papillomavirus and HPV vaccine among medical students in Lebanon. J Med Virol. 2022; 94(6): 2796-2801.
28.
Gymah Gyamfi H. Impact of gender and education on cervical cancer knowledge amongst students: implications for health policies and public health strategies in Wiesbaden, Germany. J Prev Med Hyg. 2024; 65(2): E227-E231.
29.
Nilsen K, Aasland OG, Klouman E. The HPV vaccine: knowledge and attitudes among public health nurses and general practitioners in Northern Norway after introduction of the vaccine in the school-based vaccination programme. Scand J Prim Health Care. 2017; 35(4): 387-395.
30.
Thanasa E, Thanasa A, Kamaretsos E, Paraoulakis I, Bala- fa K, Gerokostas EE, Kontogeorgis G, Koutalia N, Sta- mouli D, Grapsidi V, Alexopoulou E, Ntella G, Sfondyli E, Thanasas I. Awareness regarding human papilloma virus among health professionals and will to accept vaccination: a systematic review. Cureus. 2022; 14(10): e30855.
31.
Farsi NJ, Baharoon AH, Jiffri AE, Marzouki HZ, Merdad MA, Merdad LA. Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia. Hum Vaccin Immunother. 2021; 17(7): 1968-1974.
32.
Alghalyini B, Zaidi ARZ Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia. Hum Vaccin Immunother. 2024; 20(1): 2403844.
33.
Cheema S, Abraham A, Maisonneuve P, Jithesh A, Chaabna K, Al Janahi R, Sarker S, Hussain A, Rao S, Lowenfels AB, Mamtani R. HPV infection and vaccination: a cross- sectional study of knowledge, perception, and attitude to vaccine uptake among university students in Qatar. BMC Public Health. 2024; 24(1): 2316.
34.
Fram KM, Saleh S, Fram R, Khalaf T, Almasoud S, Almukaimi B, Tawasfshy Tawasfshy S, Aladrah M, Kharabsheh M. The shift in COVID-19 vaccination policy for pregnant women, from restricted to required, and the confusion that ensued. Menopause Rev. 2023; 22(2): 71-76.
35.
Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, Har- per DM, Levin MJ, Chatterjee A, Geeraerts B, Struyf F, Dubin G, Bozonnat MC, Rosillon D, Baril L; VIVIANE Study Group. Progression of HPV infection to detectable cervical lesions or clearance in adult women: analysis of the control arm of the VIVIANE study. Int J Cancer. 2016; 138(10): 2428-2438.
36.
Fram R, Fram KM, Saleh S, Muhidat N, Fram F, Khouri Z, Tarawneh B, Tarawneh N. Cervical cancer screening in Jordan, a review of the past and an outlook to the future; facts and figures. Menopause Rev. 2023; 22(1): 24-26.
37.
Chen G, Wu B, Dai X, Zhang M, Liu Y, Huang H, Mei K, Wu Z. Gender differences in knowledge and attitude towards HPV and HPV vaccine among college students in Wenzhou, China. Vaccines (Basel). 2021; 10(1): 10.
38.
Heimbecker V, Bordini SC, Rodrigues AC, de Alencar NM, Blanco NS, Fitz F, Moura GB, Dumitru M, Mercadante AF, Alvarenga LM, Monteiro CLB, Marconi C. Gender differences on the awareness of human papillomavirus infection and vaccination. J Cancer Educ. 2024; 39(6): 611-617.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
